These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27176133)

  • 21. Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet.
    Xavier Moreira F; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Forensic Sci Int; 2014 Sep; 242():255-260. PubMed ID: 25093918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacology of the hallucinogenic sage Salvia divinorum.
    Prisinzano TE
    Life Sci; 2005 Dec; 78(5):527-31. PubMed ID: 16213533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlates of Salvia divinorum use in a national sample: findings from the 2009 National Survey on Drug Use and Health.
    Ford JA; Watkins WC; Blumenstein L
    Addict Behav; 2011 Nov; 36(11):1032-7. PubMed ID: 21745714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvia divinorum: exposures reported to a statewide poison control system over 10 years.
    Vohra R; Seefeld A; Cantrell FL; Clark RF
    J Emerg Med; 2011 Jun; 40(6):643-50. PubMed ID: 19765944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
    Soussan C; Kjellgren A
    Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvia divinorum use among a college student sample.
    Khey DN; Miller BL; Griffin OH
    J Drug Educ; 2008; 38(3):297-306. PubMed ID: 19157046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
    Soussan C; Andersson M; Kjellgren A
    Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peak experiences of psilocybin users and non-users.
    Cummins C; Lyke J
    J Psychoactive Drugs; 2013; 45(2):189-94. PubMed ID: 23909006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. College student use of Salvia divinorum.
    Lange JE; Reed MB; Croff JM; Clapp JD
    Drug Alcohol Depend; 2008 Apr; 94(1-3):263-6. PubMed ID: 18093751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Legally high? Legal considerations of Salvia divinorum.
    Griffin OH; Miller BL; Khey DN
    J Psychoactive Drugs; 2008 Jun; 40(2):183-91. PubMed ID: 18720668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers.
    Wu LT; Woody GE; Yang C; Li JH; Blazer DG
    Subst Abuse Rehabil; 2011 Apr; 2011(2):53-68. PubMed ID: 21709724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulating a novel drug: an evaluation of changes in use of Salvia divinorum in the first year of Florida's ban.
    Stogner J; Khey DN; Griffin OH; Miller BL; Boman JH
    Int J Drug Policy; 2012 Nov; 23(6):512-21. PubMed ID: 22502947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examining the measurement of novel drug perceptions: Salvia divinorum, gender, and peer substance use.
    Miller BL; Boman JH; Stogner J
    Subst Use Misuse; 2013 Jan; 48(1-2):65-72. PubMed ID: 23025930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of use and subjective effects of Salvia divinorum among recreational users.
    González D; Riba J; Bouso JC; Gómez-Jarabo G; Barbanoj MJ
    Drug Alcohol Depend; 2006 Nov; 85(2):157-62. PubMed ID: 16720081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan.
    Lin PX; Li JH; Chen SH; Chang HC; McKetin R
    J Food Drug Anal; 2014 Sep; 22(3):370-378. PubMed ID: 28911428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvia divinorum: toxicological aspects and analysis in human biological specimens.
    Margalho C; Corte-Real F; López-Rivadulla M; Gallardo E
    Bioanalysis; 2016 Jul; 8(13):1415-25. PubMed ID: 27277872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.
    Caudevilla-Gálligo F; Riba J; Ventura M; González D; Farré M; Barbanoj MJ; Bouso JC
    J Psychopharmacol; 2012 Jul; 26(7):1026-35. PubMed ID: 22234927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample.
    Lawn W; Barratt M; Williams M; Horne A; Winstock A
    J Psychopharmacol; 2014 Aug; 28(8):780-8. PubMed ID: 24569095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Authentication and ultra performance liquid chromatography (UPLC)/MS analysis of magic mint, Salvia divinorum and its related plants].
    Maruyama T; Kamakura H; Kikura-Hanajiri R; Goda Y
    Yakugaku Zasshi; 2008 Jan; 128(1):179-83. PubMed ID: 18176071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.